Press-release for stocks

Prices are updated after-hours

GBT Opens 2021 ACCEL Grant Program, Providing up to $500,000 in Support to the Sickle Cell Disease Community
Published: 2021-03-02 (Crawled : 13:03) - globenewswire.com
GBT | $68.49 0.02% -0.02%

| 53.96% | O: -0.2% H: 3.42% C: -0.81%
disease granted

Nabriva Therapeutics Announces $25.4 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Published: 2021-03-01 (Crawled : 13:03) - globenewswire.com
NBRV | $1.42 1.39% 720K

| -40.59% | O: -15.44% H: 1.43% C: -5.0%
offering nasdaq

| -69.17% | O: 4.02% H: 2.71% C: -4.12%
dermatitis atopic dermatitis program

Onconova Therapeutics to Participate in Three Investment Conferences During the Month of March
Published: 2021-03-01 (Crawled : 13:03) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M

| -20.0% | O: 2.4% H: 5.47% C: 0.78%

Nabriva Therapeutics Appoints Daniel Dolan as Chief Financial Officer
Published: 2021-02-26 (Crawled : 13:03) - globenewswire.com
NBRV | $1.42 1.39% 720K

| -41.08% | O: 1.66% H: 2.65% C: -2.45%
therapeutics

Oncternal Therapeutics to Participate in March Investor Conferences
Published: 2021-02-24 (Crawled : 13:03) - globenewswire.com
ONCT | News | $8.6 -3.91% -1.82% 0

| 27.67% | O: 2.71% H: 5.0% C: 1.11%
conference therapeutics

Onconova Therapeutics Regains Compliance with Nasdaq Continued Listing Requirement
Published: 2021-02-24 (Crawled : 13:03) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M

| -32.43% | O: 14.19% H: 0.59% C: -8.88%
therapeutics nasdaq

VYNE Therapeutics to Report Financial Results for the Year Ended December 31, 2020 on March 4
Published: 2021-02-23 (Crawled : 13:03) - globenewswire.com
VYNE | $2.3 -4.17% -6.19% 0

| -72.39% | O: -3.96% H: 0.63% C: 0.0%
financial results results

| 1189.93% | O: -2.08% H: 0.0% C: -5.32%
disease treatment collaboration announces collaboration rare

Rubius Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Published: 2021-02-23 (Crawled : 13:03) - globenewswire.com
RUBY | $0.057 -99.3% 760K

| -99.55% | O: -5.11% H: 1.41% C: -3.16%
financial results results

Enlivex Receives Notice of Allowance for Chinese Patent Application Covering Allocetra Immunotherapy
Published: 2021-02-22 (Crawled : 13:03) - globenewswire.com
ENLV | $1.4 14K

| -92.18% | O: 1.34% H: 1.87% C: -11.29%
chinese immunotherapy therapy patent application

Aevitas Therapeutics Appoints Markus Peters, Ph.D., M.Sc., as Chief Executive Officer
Published: 2021-02-22 (Crawled : 13:03) - globenewswire.com
FBIO | $1.81 2.26% 2.21% 2K

| -59.63% | O: -1.38% H: 3.72% C: -4.42%

CytomX Therapeutics to Present at Upcoming March Virtual Investor Conferences
Published: 2021-02-22 (Crawled : 13:03) - globenewswire.com
CTMX | $1.73 -1.7% -1.44% 50

| -79.15% | O: -1.79% H: 3.42% C: -3.08%
conference presentation therapeutics

Viridian Therapeutics to Present at Three Upcoming Investor Conferences
Published: 2021-02-22 (Crawled : 13:03) - globenewswire.com
VRDN | $15.16 0.53% 0.59% 400

| -17.16% | O: 0.11% H: 3.66% C: 2.07%
conference presentation therapeutics

Morphic Therapeutic to Host Analyst and Investor Call on March 1, 2021
Published: 2021-02-22 (Crawled : 13:03) - globenewswire.com
MORF | $27.465 -0.16% 16K

| -23.35% | O: -1.73% H: 0.78% C: -3.64%